Alteration of the microRNA network during the progression of Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Alteration of the microRNA network during the progression of Alzheimer's disease.

Alteration of the microRNA network during the progression of Alzheimer's disease.

http://www.wikidata.org/entity/Q30551542

about

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders Diagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-Analysis The Transcription Repressor REST in Adult Neurons: Physiology, Pathology, and Diseases(1,2,3)Gene expression parallels synaptic excitability and plasticity changes in Alzheimer's disease Body fluid biomarkers in Alzheimer's disease Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau Competing targets of microRNA-608 affect anxiety and hypertension.MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data.Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.RNA metabolism in neurodegenerative disease.Comprehensive investigation of temporal and autism-associated cell type composition-dependent and independent gene expression changes in human brains.Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease.Epigenetic memory: the Lamarckian brain MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?Epigenomics of Alzheimer's disease.Generation of a neuro-specific microarray reveals novel differentially expressed noncoding RNAs in mouse models for neurodegenerative diseases Soluble beta-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression.The gene silencing transcription factor REST represses miR-132 expression in hippocampal neurons destined to die Transcript and protein expression decoupling reveals RNA binding proteins and miRNAs as potential modulators of human aging.Ionising radiation immediately impairs synaptic plasticity-associated cytoskeletal signalling pathways in HT22 cells and in mouse brain: an in vitro/in vivo comparison study.Soluble amyloid triggers a myeloid differentiation factor 88 and interferon regulatory factor 7 dependent neuronal type-1 interferon response in vitro Genomics in neurological disorders.Profiling of microRNAs involved in retinal degeneration caused by selective Müller cell ablation Time dynamics of protein complexes in the AD11 transgenic mouse model for Alzheimer's disease like pathology.Regulation of human MAPT gene expression.miR-132 inhibits lung cancer cell migration and invasion by targeting SOX4.A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy Evidence for a neuroprotective microRNA pathway in amnestic mild cognitive impairment.miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders.Ammonia-induced miRNA expression changes in cultured rat astrocytes.Changes in Rat Brain MicroRNA Expression Profiles Following Sevoflurane and Propofol Anesthesia.microRNA Profiles in Parkinson's Disease Prefrontal Cortex miR-186 is decreased in aged brain and suppresses BACE1 expression MicroRNA-146a suppresses ROCK1 allowing hyperphosphorylation of tau in Alzheimer's disease The miR-132/212 locus: a complex regulator of neuronal plasticity, gene expression and cognition Identifying significant gene-environment interactions using a combination of screening testing and hierarchical false discovery rate control.

P2860

Q21129476-9FEF1102-078A-40E6-830D-D719DC6684F4 Q26768181-2B4330F4-FF49-4731-A1CE-D9B7087C28C7 Q26783252-C336687C-D35C-4D82-A8BD-7C938909D820 Q26785375-C161F529-C3A1-47FD-81B3-FE56DAB50F7E Q26830098-13FA11D8-07B2-46A2-9485-28B5D26EA748 Q28077671-EDF426A2-A618-4AD6-820D-162D8D5B51DC Q28255230-F479B8C0-6196-4A39-B93C-6FF11A1AB811 Q30585666-5AC52B96-586A-4CBD-ABC6-C167A7300BD1 Q30940333-A182D781-92C5-4B19-95D7-C7715A5DFA41 Q33567669-767B7F28-1E57-429A-8294-F59BE1A4C7AB Q33732095-C7C43516-480C-4A4F-A73D-8628380F993A Q33746283-7C90F252-6EC6-4EAE-B0AD-7A37306EF347 Q33830105-93B74968-2EA7-4012-B8FC-C2881DEE02CC Q33862621-6CDCB02F-A92E-4E40-9CBD-B97E2211BABF Q34323841-E65D6D36-093A-4812-B5F9-C22926C22663 Q34324544-98C3EB5F-3784-4A7D-BEFA-E59EDF54BDC6 Q34426210-55C79276-455D-40C8-8FEC-0295FC12DDFB Q34518584-E72F98E0-4ABF-4D28-81AC-EDE7646D3A29 Q34547209-869B2767-5EE9-4D36-A350-163832F1500A Q35111407-54A6188C-A8C5-4FCA-B2EA-61BE0FC0C524 Q35216968-3CF72154-7D97-4DF0-AB11-1DFF99C2F664 Q35222558-44EDB49F-1D57-43A9-AC04-08AD7144E455 Q35348622-196DDFA6-C69C-4AD6-8ECE-E6D4192D6D8E Q35531082-B286B69B-401B-49F9-8D12-9572FFD1ECC9 Q35543494-EE1FD638-C3C0-4942-971A-11EC0B98C901 Q35571995-C0629020-F87A-4814-91B6-266142659D2D Q35618276-B78BA8D4-3219-431F-8696-6ADE3CFD46D8 Q35844758-F1847F3E-C955-4C62-B57C-4A07405310FA Q36138348-0B27C8AC-DCD4-4188-A8E6-BC1D43F6F194 Q36246459-513F9498-5DB9-4026-B520-365011EFE5AD Q36249445-6C22D2D9-6ECD-4269-9DD2-748664B61C75 Q36251998-720C34BD-454C-44B1-83DC-9F10664C0A71 Q36424672-6C9C3826-F8E7-4213-AD02-D8219781F1D7 Q36453461-3776273C-65ED-4B51-9D9F-15E8C0FC6DAE Q36523254-6FD5BBC4-8628-4E6C-B2A5-398F334AB1A0 Q36634755-6F6F8B78-9D03-4E79-834C-5D6A44C6671B Q36813933-4DDC83BD-2023-4B41-8225-8862B9102DB8 Q36934113-27240C22-8703-4358-A382-0F7C4EF40432 Q37309425-D3BE7AF7-CC53-4BF7-B027-331228FF30A4 Q37412785-68FAF707-5348-4647-BE70-E33D1420991B

P2860

Alteration of the microRNA network during the progression of Alzheimer's disease.

http://www.wikidata.org/entity/Q30551542

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Alteration of the microRNA network during the progression of Alzheimer's disease.

@ast

Alteration of the microRNA network during the progression of Alzheimer's disease.

@en

type

label

Alteration of the microRNA network during the progression of Alzheimer's disease.

@ast

Alteration of the microRNA network during the progression of Alzheimer's disease.

@en

prefLabel

Alteration of the microRNA network during the progression of Alzheimer's disease.

@ast

Alteration of the microRNA network during the progression of Alzheimer's disease.

@en

P1433

Q30551542-D5344D7F-F3A4-4D84-A34F-3A7B9D67BE9E

P1476

Q30551542-28A5F051-F206-4145-8AE4-6BB19A095EEA

P2093

Q30551542-017DFEE7-FA82-4DCA-BB4B-514DAC002784

Q30551542-26EB0140-F743-4348-9168-8AF2A1551C6B

Q30551542-3B396661-7F7E-4DB6-9FB5-75C830A1F6F0

Q30551542-5B3F2936-D687-4616-83BF-D068D1691DFD

Q30551542-62B4A1A0-9E7A-4D0B-9ADE-84E75DC28413

Q30551542-63C2C06A-B9B9-4791-ABE4-921D2D8C752E

Q30551542-73965CED-3E7F-4485-B4F4-6BA25A2CB2C1

Q30551542-748B4407-3D14-4859-BA79-60E7A9F653FD

Q30551542-B3B50D71-3F19-4E60-88DF-64BF5E4C1277

Q30551542-D0C7AED7-6F5F-43C8-AD2F-B126B29A0CD0

P2860

Q30551542-005F36B6-31DA-44D2-BCB4-F3FB97D0EC03

Q30551542-027C4013-45FD-4B85-9E3B-CD061F64E1A6

Q30551542-094B522F-1CA1-4771-B59F-F6EAF8669DE1

Q30551542-0A44EF74-9013-4A44-BC41-001654CC9B14

Q30551542-0EAE70DC-307C-4EAD-8D24-B823E8151587

Q30551542-0EC6A221-7200-44C8-8205-4BB0078E2561

Q30551542-1133B53E-858A-45D8-9CB9-5172FFA60B53

Q30551542-13A08E4A-10F7-489A-914C-68044BAD3CC5

Q30551542-15027DC2-5CA6-4582-A835-207216259AE2

Q30551542-1EEA3E54-41DE-4167-A537-15282D804162

P304

Q30551542-8F9F2EB4-BC89-4BDB-9306-960415A1BB2F

P31

Q30551542-8C215468-2FEB-4A7C-849E-7FBA0926CE10

P356

Q30551542-E47B5C0A-E09E-4D8B-A999-171F4B7FE423

P433

Q30551542-2520654F-4074-4FF6-9267-468F33E1F57C

P478

Q30551542-EF1F34A6-54D0-412C-9945-BC29932669D6

P50

Q30551542-3D989B8F-7C94-46F6-AA3F-97AEB571278F

Q30551542-671061FE-6CE4-4C9D-A7BE-AD139A0A5D97

Q30551542-9173934C-85F4-48C6-A263-F9453B0BA9C0

Q30551542-ACF919EE-1264-4E75-A6FE-3C0BB2774E02

Q30551542-F33E98F8-E45C-4FAE-B912-D7C1F0085EB2

P577

Q30551542-8328EDEB-A05F-4443-B0DA-AE740D37BA72

P5875

Q30551542-706E2112-7D63-41A6-A01F-C054F47D1893

P698

Q30551542-B1C1C9C8-5901-4082-A983-2D75E987A266

P921

Q30551542-2092E769-A2F1-4E27-8F11-F8E21CED354B

Q30551542-6BEE8A30-AF5C-401F-A775-79C68B33D7A1

P932

Q30551542-48A5C7EA-8C93-4246-ABE0-3D56A71134E1

P356

P1433

EMBO Molecular Medicine

P1476

Alteration of the microRNA network during the progression of Alzheimer's disease.

@en

P2093

Aikaterini S Papadopoulou

http://www.w3.org/2001/XMLSchema#string

Amantha Thathiah

http://www.w3.org/2001/XMLSchema#string

Annerieke S R Sierksma

http://www.w3.org/2001/XMLSchema#string

David Greenberg

http://www.w3.org/2001/XMLSchema#string

Evgenia Salta

http://www.w3.org/2001/XMLSchema#string

Hermona Soreq

http://www.w3.org/2001/XMLSchema#string

Joost Verhaagen

http://www.w3.org/2001/XMLSchema#string

Pierre Lau

http://www.w3.org/2001/XMLSchema#string

Rekin's Janky

http://www.w3.org/2001/XMLSchema#string

Roy Rothman

http://www.w3.org/2001/XMLSchema#string

P2860

Differential expression analysis for sequence count data

A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis.

Cholinergic-associated loss of hnRNP-A/B in Alzheimer's disease impairs cortical splicing and cognitive function in mice

Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities

microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus

MicroRNA profiling: approaches and considerations

The genetics of Alzheimer disease

Neuropathological stageing of Alzheimer-related changes

MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase

Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways

P304

1613-1634

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EMMM.201201974

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Bart De Strooper

Carlo Sala Frigerio

P577

2013-09-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256469778

http://www.w3.org/2001/XMLSchema#string

P698

24014289

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3799583

http://www.w3.org/2001/XMLSchema#string